Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study. Murtagh R, Swan D, O'Connor E, McCombe G, Lambert JS, Avramovic G, Cullen W. Inter…

Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration. Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS, Cullen W. Health Justice. 2018 Dec 19;6(1):23. doi: 10.11…

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents. Gualerzi A, Bellan M, Smirne C, Tran Minh M, Rigamonti C, Burlone ME, et al. (2018)  PLoS ONE 13(12): e020…

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road? Bourlière M, Pietri O, Castellani P, Oules V, Adhoute X. Therap Adv Gastroenterol. 2018 Dec 2;…

Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy. Villani R, Vendemiale G, Serviddio G. Int J Mol Sci. 2018 Dec 22;20(1). pii: E49. doi: 10.3390/ijms20010049. Review. https://www.mdpi.com/1422-0067/20/1/49

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, et al. (2018)  PLoS ONE 13(12): e0209374. doi.org/10.1371/journal.pone.02093…